ULTRAGENYX PHARMACEUTICAL Soars with 42% Increase in Revenue for Third Quarter 2024
☀️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE) is a leading biopharmaceutical company that specializes in developing transformative treatments for rare and ultra-rare [...]
Fred Alger Management LLC reduces stake in Ultragenyx Pharmaceutical by 5.6% in 2nd quarter
🌥️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. is a biopharmaceutical company focused on developing treatments for rare genetic diseases. The company's [...]
Ultragenyx Pharmaceutical Stock Fair Value – Candriam S.C.A. Boosts Investment in Ultragenyx Pharmaceutical Inc
☀️Trending News Candriam S.C.A., a global asset management firm, has recently announced its decision to increase its investment in Ultragenyx [...]
Ultragenyx Pharmaceutical Experiences a Year of Volatile Stock Market Performance
🌥️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. is a clinical-stage biopharmaceutical company that develops treatments for rare and ultra-rare genetic diseases. [...]
Wells Fargo Gives Ultragenyx Pharmaceuticals Overweight Rating on Initial Coverage
🌧️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE)s Inc. has recently been given an overweight rating by Wells Fargo. This is the first [...]
Ultragenyx Pharmaceutical Intrinsic Value Calculator – ULTRAGENYX PHARMACEUTICAL Reports Second Quarter Earnings for FY2023
🌥️Earnings Overview ULTRAGENYX ($NASDAQ:RARE): For the second quarter of FY2023, ULTROGENYX PHARMACEUTICAL recorded total revenue of USD 108.3 million, representing [...]
Ultragenyx Pharmaceutical Stock Fair Value – Nineteen Research Analysts Recommend “Moderate Buy” for Ultragenyx Pharmaceutical Shares
☀️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. is a biopharmaceutical company based in the United States, focused on developing treatments for [...]
Ultragenyx Pharmaceutical Stock Fair Value – Ultragenyx and Mereo Show Positive Results in Phase 2 Trials for Bone Disorder Treatment
☀️Trending News Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO) have recently seen an increase [...]
Ultragenyx Pharmaceutical Stock Fair Value – Ultragenyx: A Resilient Rare Disease Pharma Despite OI Trial Doubts
Trending News ☀️ Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc, a biopharmaceutical company based in Novato, California, is a leader in the rare [...]
GlobalData: Ultragenyx’s UX053 Phase I/II Study Termination a Minor Setback for mRNA Therapeutics
Trending News 🌥️ Ultragenyx Pharmaceutical ($NASDAQ:RARE) Inc. is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of novel [...]
